Safe and effective, prolonged administration of epsilon aminocaproic acid in bleeding from the urinary tract.
A total of 9 patients with macroscopic hematuria from various causes, none with evidence of disseminated intravascular coagulation, received low oral, divided doses (approximately 150 mg. per kg. per day) of epsilon aminocaproic acid for up to 21 consecutive days. The hematuria was controlled effectively without overt clinical reactions. Parameters of hepatic and renal function, indicators of muscular damage, were studied in detail in 3 patients. No significant abnormalities were found. The use of small doses of epsilon aminocaproic acid was not accompanied by significant complications and appeared to be effective in special situations for the control of urinary bleeding. This therapy may have indications in a number of urological states accompanied by excessive hematuria.
Stefanini
M
M
Department of Pathology, Saint Elizabeth Hospital, Danville, Illinois.
English
H A
HA
Taylor
A E
AE
D000328:Adult; D000368:Aged; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D006417:Hematuria / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male
D000614:Aminocaproates; D015119:Aminocaproic Acid